CNN Exclusive: The futuristic foam that stops deadly internal bleeding
CNN spoke with the first person in the world to be treated with this futuristic material, called Res-Q-Foam, after he was seriously injured in a car crash last year and had just moments to live. Watch
Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension
CAMBRIDGE, Mass. – March 28, 2026 – Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device (SaMD) that detects early signs of PH, a... Read More →
How Genalyte Is Turning Same-Visit Diagnostics Into Lifesaving Decisions
Patient Stories: How MedTech Innovator alumni are transforming lives At MedTech Innovator we empower healthtech companies to bring groundbreaking solutions to patients in need. Our Patient Stories series highlights the real-world clinical impact of the companies we support—showcasing how their... Read More →
Starlight Cardiovascular Announces First Baby in the World Treated with Lifeline Stent System at Cincinnati Children’s Hospital
SAN DIEGO, March 24, 2026 /PRNewswire/ — Starlight Cardiovascular announced that the first baby in the world was treated with its Lifeline™ Ductus Arteriosus Stent System at Cincinnati Children’s Hospital in January. The device is currently being studied under a... Read More →
Xenocor Appoints David McNally as Chief Executive Officer, Antony Watson to Chief Commercial Officer and David Van Ness to Chief Technology Officer
Medical device industry veteran to lead expansion of Saberscope™, the market’s first and only single-use video platform for minimally invasive surgery, laparoscopic procedures, and advanced surgical visualization technologies. Xenocor announces David McNally as CEO and leadership appointments as the company... Read More →
AI-Enhanced ECG flags aortic stenosis years before symptoms featuring AccurKardia
Matthew Segar, MD, of The Texas Heart Institute, discusses new research evaluating whether AI‑enabled ECG analysis can detect aortic stenosis years before traditional symptom‑driven diagnosis. Because echocardiography is effective but not scalable for population screening, his team applied the previously... Read More →
Toro Neurovascular Announces FDA 510(k) Clearance for Toro 88 Superbore Catheter
First clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular division IRVINE, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Toro Neurovascular today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the... Read More →
Vitestro Raises $70 Million in Oversubscribed Series B Financing to Advance Autonomous Robotic Phlebotomy and Commercial Readiness
Labcorp Venture Fund, Mayo Clinic, Sutter Health, InterVest, MGFO, PGGM, Puma Venture Capital, and ROM Utrecht invest alongside existing investors Invest-NL, EIC Fund, Fred Moll, NYBC Ventures, and Sonder Capital. Utrecht, The Netherlands, March 10, 2026 – Vitestro, the pioneer... Read More →
May Health Raises $11.7M to Advance its Novel Technology to Treat PCOS-related Infertility
New investor Nexpring Health™ joins existing investors, including Sofinnova, Bpifrance, and Trill Impact MENLO PARK, Calif.–(BUSINESS WIRE)–May Health, a medical device company dedicated to helping women living with polycystic ovary syndrome (PCOS), today announced that it raised €10 million ($11.7M)... Read More →
From animal models to organoids: how functional data fits regulatory expectations featuring Diagnostic Biochips
The landscape of preclinical neuroscience research is shifting. Growing ethical considerations, cost pressures, and translational limitations have accelerated interest in organoid alternatives to animal models in neuroscience. While animal models have long served as the foundation for safety and efficacy... Read More →